Novozymes A/S (CPH: NSIS.B)
468.00
+2.80 (0.60%)
Aug 30, 2024, 4:59 PM CET
Novozymes Revenue
Novozymes had revenue of 915.85M DKK in the quarter ending June 30, 2024, with 61.70% growth. This brings the company's revenue in the last twelve months to 3.04B, up 27.85% year-over-year. In the year 2023, Novozymes had annual revenue of 17.90B with 1.97% growth.
Revenue (ttm)
3.04B
Revenue Growth
+27.85%
P/S Ratio
5.70
Revenue / Employee
2.17M
Employees
6,756
Market Cap
217.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 17.90B | 346.00M | 1.97% |
Dec 31, 2022 | 17.55B | 2.60B | 17.40% |
Dec 31, 2021 | 14.95B | 939.00M | 6.70% |
Dec 31, 2020 | 14.01B | -362.00M | -2.52% |
Dec 31, 2019 | 14.37B | -16.00M | -0.11% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SP Group A/S | 2.72B |
H+H International A/S | 2.67B |
Flügger group A/S | 2.21B |
RIAS A/S | 307.11M |
Scandinavian Investment Group A/S | 28.00M |
Hove A/S | 176.31M |
Novo Nordisk A/S | 258.00B |
Nordea Bank Abp | 88.10B |
Novozymes News
- 7 months ago - Invitation to an extraordinary shareholders' meeting of Novozymes A/S - GlobeNewsWire
- 7 months ago - The Novozymes Report 2023 - GlobeNewsWire
- 7 months ago - Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed - GlobeNewsWire
- 7 months ago - Legacy Novozymes delivers solid last full-year results - GlobeNewsWire
- 7 months ago - Completion of the combination between Novozymes and Chr. Hansen - GlobeNewsWire
- 7 months ago - The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner - GlobeNewsWire
- 7 months ago - All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen - GlobeNewsWire
- 9 months ago - Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted - GlobeNewsWire